Study #2020-0732
Discovery of Actionable Biomarkers in HER2-Positive Breast Cancer
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Biomarkers in HER2-Positive Breast Cancer
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Department:
Breast Medical Oncology
For general questions about clinical trials:
1-877-734-0338
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.